BRAP
BRAPgeneBRAP is a genetic risk variant associated with CAD and MI but does not directly participate in the atherothrombotic cascade mechanism.
Pathway placement
Cascade stepOff-pathway / systemic markers
Confidencelow
RationaleCAD and MI susceptibility locus; genetic risk independent of mechanistic pathway.
Druggability
DruggableNo
Known drugs / candidates0
Small-molecule tractableNo
Antibody tractableNo
EnsemblENSG00000089234
Assay & specimen
Class-level default (no specific cleared assay)— generic method inferred from analyte class; confirm against a specific product insert before use.
Specimen
Whole blood — gene is not a circulating analyte; measure protein product or genotype
Collection tube
K2-EDTA whole blood (lavender-top)
Method / principle
SNP genotyping / sequencing; or immunoassay of encoded protein
Reagent / substrate
Allele-specific primers/probes (TaqMan) or NGS panel; or antibody for protein
Platform
qPCR / NGS / array
Turnaround · availability
Send-out · Genotyping widely available; protein assay variable
Human genetic evidence
2
GWAS associations
Traits: myocardial infarction
Literature evidence(5)
- Shared Genetic Liability Between Heart Failure and Myocardial Infarction Revealed by Genome-Wide Cross-Trait Analysis.Journal of cardiovascular pharmacology and therapeutics · 2026 · PMID 42141940 · doi
- Molecular genetics of coronary artery disease.Journal of human genetics · 2015 · PMID 26134515 · doi
- A genome-wide association study of a coronary artery disease risk variant.Journal of human genetics · 2013 · PMID 23364394 · doi
- Genome-wide association study of coronary artery disease in the Japanese.European journal of human genetics : EJHG · 2011 · PMID 21971053 · doi
- [Genetic background of acute coronary syndrome].Nihon rinsho. Japanese journal of clinical medicine · 2010 · PMID 20387550